glp 1 drugs and dementia GLP-1 Might Cut Risk in Half GLP-1 Dementia Risk: Hype or

The neuroprotective effect of exendin-4 was found to be independent of the glucose-increasing effect, whereas related to increasing the levels of cAMP and reducing oxidative stress and the inflammatory response (83)

Multiple patient-specific and medication-related factors influence the speed and magnitude of response to GLP-1 receptor agonists

For injectable GLP-1 RAs, PPI interactions are not expected because the mechanism involves gastric transit, not gastric pH

The FDA accepted Novo Nordisks NDA for an oral formulation of Wegovy

doi: 10.1016/j.ijcard.2011.09.039 [DOI] [PubMed] [Google Scholar] 260

Early studies suggest that GLP-1 might also support emotional well-being